Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone

Dermatologic Surgery

Volumn 36, Issue SUPPL. 3, 2010, Pages 1852-1858

  Custis, Trenton ^a   Beynet, David ^a,b   Carranza, Dafnis ^a   Greco, Joseph ^a   Lask, Gary P ^a,c   Kim, Jenny ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c Lask and Rosenzweig Dermatology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; HYALURONIC ACID; ONABOTULINUMTOXIN A; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INJECTION SITE SWELLING; MALE; MELOMENTAL FOLD RHYTIDE; MONOTHERAPY; PATIENT SATISFACTION; PRIORITY JOURNAL; SKIN DEFECT; SKIN REDNESS; TREATMENT OUTCOME;

BOTULINUM TOXINS, TYPE A; CROSS-LINKING REAGENTS; DRUG THERAPY, COMBINATION; FACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; RHYTIDOPLASTY; SKIN AGING; TREATMENT OUTCOME;

EID: 78349300537     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01741.x     Document Type: Article

References (9)

1. Freidman O., Changes associated with the aging face. Facial Plast Surg Clin North Am 2005; 13: 371-80.
2. Perkins NW, Smith SP Jr, Williams EF III, Perioral rejuvenation: complementary techniques and procedures. Facial Plast Surg Clin North Am 2007; 15: 423-32; vi.
3. Suryadevara AC., Update on perioral cosmetic enhancement. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 347-51.
4. Kane MAC., Botox injections for lower facial rejuvenation. Oral Maxillofacial Surg Clin N Am 2005; 17: 41-9.
5. Klein AW, Fagien S., Hyaluronic acid fillers and botulinum toxin type A: rationale for their individual and combined use for injectable facial rejuvenation. Plast Reconstr Surg 2007; 120 (6 Suppl): 81S-8S.
6. Kaplan SE, Sherris DA, Gassner HG, Friedman O., The use of botulinum toxin A in perioral rejuvenation. Facial Plast Surg Clin North Am 2007; 15: 415-21, v-vi.
7. Carruthers J, Carruthers A., A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid(NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003; 29: 802-9.
8. Carruthers A, Kiene K, Carruthers J., Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996; 34 (5 Pt 1): 788-97.
9. Carruthers J, Fagien S, Matarasso SL, Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 2004; 114 (6 Suppl): 1S-22S.